CDH2 and cancer: For example, studies have reported that aberrant regulation of EMT-related epithelial (E-cadherin) and mesenchymal (vimentin, N-cadherin) markers have been identified in CRC and are associated with increased rate of cancer recurrence, metastasis, and poor prognosis of CRC patients (27-, , 30).